Quantcast

IQVIA to Participate in William Blair Growth Stock Conference on June 5, 2019

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ari
Bousbib, chairman and chief executive officer, will speak at the William
Blair 39th Annual Growth Stock Conference in Chicago, IL on Wednesday,
June 5, 2019 at 10:40 a.m. CT / 11:40 a.m. ET.

A live audio webcast of the presentation will be available on the IQVIA
Investor Relations website, and a replay of the webcast also will be
available beginning later that day. To access the webcast and recording,
visit http://ir.iqvia.com.

About IQVIA

IQVIA is a leading global provider of advanced analytics, technology
solutions and contract research services to the life sciences industry.
Formed through the merger of IMS Health and Quintiles, IQVIA applies
human data science — leveraging the analytic rigor and clarity of data
science to the ever-expanding scope of human science — to enable
companies to reimagine and develop new approaches to clinical
development and commercialization, speed innovation and accelerate
improvements in healthcare outcomes. Powered by the IQVIA CORE™, IQVIA
delivers unique and actionable insights at the intersection of
large-scale analytics, transformative technology and extensive domain
expertise, as well as execution capabilities. With more than 58,000
employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The
company uses a wide variety of privacy-enhancing technologies and
safeguards to protect individual privacy while generating and analyzing
information on a scale that helps healthcare stakeholders identify
disease patterns and correlate with the precise treatment path and
therapy needed for better outcomes. IQVIA’s insights and execution
capabilities help biotech, medical device and pharmaceutical companies,
medical researchers, government agencies, payers and other healthcare
stakeholders tap into a deeper understanding of diseases, human
behaviors and scientific advances, in an effort to advance their path
toward cures. To learn more, visit www.iqvia.com.

IQVIAFIN

Click
here to subscribe to Mobile Alerts for IQVIA.

Contacts

Andrew Markwick, IQVIA Investor Relations ([email protected])
+1.973.257.7144

Tor
Constantino, IQVIA Media Relations ([email protected])
+1.484.567.6732

Read the full article

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.